Agios Pharma (AGIO) Misses Q3 EPS by 11c

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.63), $0.11 worse than the analyst estimate of ($1.52). Revenue for the quarter came in at $9 million versus the consensus estimate of $7.82 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• Innovex closes $95M acquisition of TCO Group AS
• Whirlpool to close Mexico plant, expects $165M restructuring cost